These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 27180831)
1. Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort. Smith SL; Plant D; Lee XH; Massey J; Hyrich K; Morgan AW; Wilson AG; Isaacs J; Barton A Pharmacogenomics; 2016 May; 17(7):715-20. PubMed ID: 27180831 [TBL] [Abstract][Full Text] [Related]
2. GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis. Acosta-Colman I; Palau N; Tornero J; Fernández-Nebro A; Blanco F; González-Alvaro I; Cañete JD; Maymó J; Ballina J; Fernández-Gutiérrez B; Olivé A; Corominas H; Erra A; Canela-Xandri O; Alonso A; López Lasanta M; Tortosa R; Julià A; Marsal S Pharmacogenomics; 2013 May; 14(7):727-34. PubMed ID: 23651021 [TBL] [Abstract][Full Text] [Related]
3. Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis. Julià A; Ferrándiz C; Dauden E; Fonseca E; Fernández-López E; Sanchez-Carazo JL; Vanaclocha F; Puig L; Moreno-Ramírez D; Lopez-Estebaranz JL; Herrera E; de la Cueva P; Ávila G; Alonso A; Tortosa R; López-Lasanta M; Marsal S Pharmacogenomics J; 2015 Aug; 15(4):322-5. PubMed ID: 25403996 [TBL] [Abstract][Full Text] [Related]
4. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort. Plant D; Prajapati R; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A Arthritis Rheum; 2012 Mar; 64(3):665-70. PubMed ID: 21952740 [TBL] [Abstract][Full Text] [Related]
5. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways. Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286 [TBL] [Abstract][Full Text] [Related]
6. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis. Márquez A; Ferreiro-Iglesias A; Dávila-Fajardo CL; Montes A; Pascual-Salcedo D; Perez-Pampin E; Moreno-Ramos MJ; García-Portales R; Navarro F; Moreira V; Magro C; Caliz R; Ferrer MA; Alegre-Sancho JJ; Joven B; Carreira P; Balsa A; Vasilopoulos Y; Sarafidou T; Cabeza-Barrera J; Narvaez J; Raya E; Cañete JD; Fernández-Nebro A; Ordóñez Mdel C; de la Serna AR; Magallares B; Gomez-Reino JJ; González A; Martín J Arthritis Res Ther; 2014 Mar; 16(2):R66. PubMed ID: 24612463 [TBL] [Abstract][Full Text] [Related]
7. Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis. Hassan B; Maxwell JR; Hyrich KL; ; Barton A; Worthington J; Isaacs JD; Morgan AW; Wilson AG Rheumatology (Oxford); 2010 Jan; 49(1):43-7. PubMed ID: 19926672 [TBL] [Abstract][Full Text] [Related]
8. A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis. Honne K; Hallgrímsdóttir I; Wu C; Sebro R; Jewell NP; Sakurai T; Iwamoto M; Minota S; Jawaheer D Arthritis Res Ther; 2016 Jan; 18():12. PubMed ID: 26776603 [TBL] [Abstract][Full Text] [Related]
9. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study. Canet LM; Filipescu I; Cáliz R; Lupiañez CB; Canhão H; Escudero A; Segura-Catena J; Soto-Pino MJ; Ferrer MA; García A; Romani L; Pérez-Pampin E; González-Utrilla A; López Nevot MA; Collantes E; Fonseca JE; Sainz J Pharmacogenet Genomics; 2015 Jul; 25(7):323-33. PubMed ID: 25850964 [TBL] [Abstract][Full Text] [Related]
10. PDE3A-SLCO1C1 locus is associated with response to anti-tumor necrosis factor therapy in psoriatic arthritis. Julià A; Rodríguez J; Fernández-Sueiro JL; Gratacós J; Queiró R; Montilla C; Torre-Alonso JC; Pérez-Venegas JJ; Manrique-Arija S; Muñoz-Fernández S; González C; Roig D; Zarco P; Erra A; Castañeda S; García A; Salvador G; Díaz-Torne C; Blanco R; Domínguez AW; Mosquera JA; Vela P; Tornero J; Sánchez-Fernández S; Corominas H; Ramírez J; Avila G; Alonso A; Tortosa R; López-Lasanta M; Cañete JD; Marsal S Pharmacogenomics; 2014 Nov; 15(14):1763-1769. PubMed ID: 25493569 [TBL] [Abstract][Full Text] [Related]
11. Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis. Eektimmerman F; Swen JJ; Böhringer S; Huizinga TW; Kooloos WM; Allaart CF; Guchelaar HJ Pharmacogenomics; 2017 Jul; 18(10):945-953. PubMed ID: 28639493 [TBL] [Abstract][Full Text] [Related]
12. Association of anti-CCP positivity and carriage of TNFRII susceptibility variant with anti-TNF-α response in rheumatoid arthritis. Vasilopoulos Y; Bagiatis V; Stamatopoulou D; Zisopoulos D; Alexiou I; Sarafidou T; Settas L; Sakkas L; Mamouris Z Clin Exp Rheumatol; 2011; 29(4):701-4. PubMed ID: 21813066 [TBL] [Abstract][Full Text] [Related]
13. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts. Sánchez-Maldonado JM; Cáliz R; López-Nevot MÁ; Cabrera-Serrano AJ; Moñiz-Díez A; Canhão H; Ter Horst R; Quartuccio L; Sorensen SB; Glintborg B; Hetland ML; Filipescu I; Pérez-Pampin E; Conesa-Zamora P; Swierkot J; den Broeder AA; De Vita S; Petersen ERB; Li Y; Ferrer MA; Escudero A; Netea MG; Coenen MJH; Andersen V; Fonseca JE; Jurado M; Bogunia-Kubik K; Collantes E; Sainz J Front Immunol; 2021; 12():672255. PubMed ID: 34777329 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Liu C; Batliwalla F; Li W; Lee A; Roubenoff R; Beckman E; Khalili H; Damle A; Kern M; Furie R; Dupuis J; Plenge RM; Coenen MJ; Behrens TW; Carulli JP; Gregersen PK Mol Med; 2008; 14(9-10):575-81. PubMed ID: 18615156 [TBL] [Abstract][Full Text] [Related]
15. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis. Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A Front Immunol; 2019; 10():1459. PubMed ID: 31312201 [No Abstract] [Full Text] [Related]
16. Estimation of heritability of different outcomes for genetic studies of TNFi response in patients with rheumatoid arthritis. Umićević Mirkov M; Janss L; Vermeulen SH; van de Laar MA; van Riel PL; Guchelaar HJ; Brunner HG; Albers CA; Coenen MJ Ann Rheum Dis; 2015 Dec; 74(12):2183-7. PubMed ID: 25114059 [TBL] [Abstract][Full Text] [Related]
17. Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis. Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NHH; Andersen V Pharmacogenomics J; 2018 Jan; 18(1):81-86. PubMed ID: 27698401 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept. Ferreiro-Iglesias A; Montes A; Perez-Pampin E; Cañete JD; Raya E; Magro-Checa C; Vasilopoulos Y; Caliz R; Ferrer MA; Joven B; Carreira P; Balsa A; Pascual-Salcedo D; Blanco FJ; Moreno-Ramos MJ; Manrique-Arija S; Ordoñez MDC; Alegre-Sancho JJ; Narvaez J; Navarro-Sarabia F; Moreira V; Valor L; Garcia-Portales R; Marquez A; Gomez-Reino JJ; Martin J; Gonzalez A PLoS One; 2019; 14(2):e0213073. PubMed ID: 30818333 [TBL] [Abstract][Full Text] [Related]
19. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis. Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NH; Andersen V PLoS One; 2015; 10(10):e0139781. PubMed ID: 26440629 [TBL] [Abstract][Full Text] [Related]
20. Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis. Swierkot J; Bogunia-Kubik K; Nowak B; Bialowas K; Korman L; Gebura K; Kolossa K; Jeka S; Wiland P Joint Bone Spine; 2015 Mar; 82(2):94-9. PubMed ID: 25311255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]